Proposed mechanisms of Tesamorelin: Activates GHRH receptors Increases endogenous GH release Elevates IGF-1 production Promotes lipolysis Reduces visceral adipose tissue Why Tesamorelin is unique: Unlike most weight-loss therapies, Tesamorelin appears particularly effective at reducing visceral fat the deep abdominal fat surrounding internal organs that is strongly associated with insulin resistance, cardiovascular disease, and metabolic syndrome
Tesofensine is not approved by the FDA for fat loss or fitness-related use and is sold strictly for research purposes
Further research is needed to help identify the exact link between GLP-1 drugs and reduced alcohol cravings
In many patients with IC/PBS, these signaling pathways are found to be either dysfunctional or interrupted at some point during the diseases progression (Hanno and Dmochowski, 2009
BPC-157 (Body Protection Compound-157) is a synthetic peptide derived from human gastric juice that shows remarkable potential for accelerating soft tissue recovery in combat sports athletes
Was the study conducted in animals or humans